Saturday, February 5, 2022

Feinstein Institutes Awarded $2.7M From NIH to Research Shock, Sepsis Therapeutic Targets

 Feinstein Institutes Awarded $2.7M From NIH to Research Shock, Sepsis Therapeutic Targets

MANHASSET, N.Y., January 27, 2022--(BUSINESS WIRE)--Uncontrolled bleeding or hemorrhagic shock (HS) is the main cause of death in Americans younger than age 44 and accounts for nearly one-third of all deaths following severe traumatic injury. 

No comments:

Post a Comment